MET and hepatocellular carcinoma: To this end, we employed two innovative tumor models in this study: a subcutaneous model constructed using primary HCC cells (c-Met/sgPten) and an orthotopic model established via hydrodynamic injection of Akt/Nras/SB plasmids into the tail vein.